Clinical trials
Completed Phase 2 Cystic Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
133 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 9 |
| 2006 | 5 |
| 2007 | 9 |
| 2008 | 14 |
| 2009 | 5 |
| 2010 | 9 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 9 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 133 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 17 |
| Lakefront Biotherapeutics NV | 5 |
| Merck Sharp & Dohme LLC | 4 |
| PTC Therapeutics | 4 |
| Syntara | 4 |
| The Hospital for Sick Children | 4 |
| Entero Therapeutics | 3 |
| Gilead Sciences | 3 |
| Johns Hopkins University | 3 |
| AlgiPharma AS | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystic Fibrosis | 133 |
| Exocrine Pancreatic Insufficiency | 9 |
| Pseudomonas Infections | 9 |
| Lung Diseases | 7 |
| Genetic Diseases, Inborn | 4 |
| Inflammation | 3 |
| Respiratory Tract Diseases | 3 |
| Bacterial Infections | 2 |
| Bronchiectasis | 2 |
| Infant, Newborn, Diseases | 2 |
Trials
Showing 1 to 25 of 133. Each trial links to its page on Pharma Observatory.
33 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.